T. Rowe Price Investment Management, Inc.

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1897612 BALTIMORE, MD

Position in SRPT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$24,660,782

+$5,463,544 QoQ

Shares Held

1,133,308

+27.0% QoQ

Ownership

1.07%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 98.83553279426246.ToString("F0")% Shared 0.ToString("F0")% None 1.16446720573754.ToString("F0")%

Healthcare · as of Mar 31, 2026

T. Rowe Price Investment Management, Inc. holds $11,176,949,825 across 48 Biotechnology names. SRPT ranks #35 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	5,193,324	$1,718,315,111
2	ASND	Ascendis Pharma A/S	6,162,042	$1,409,443,866
3	CYTK	Cytokinetics Inc	17,523,840	$1,154,996,294
4	APGE	Apogee Therapeutics, Inc.	10,300,984	$867,033,823
5	PCVX	Vaxcyte, Inc.	12,126,017	$704,642,847
6	DYN	Dyne Therapeutics, Inc.	30,785,801	$558,146,572
7	BNTX	BioNTech SE	5,856,073	$520,487,768
8	IONS	Ionis Pharmaceuticals Inc	6,159,027	$462,481,337

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$24,660,782	1,133,308	+27.0%	Shares	Sole	2026-05-15
2025-12-31	$19,197,238	892,065	-34.7%	Shares	Sole	2026-02-19
2025-09-30	$26,336,116	1,366,690	+187.9%	Shares	Sole	2025-11-14
2025-06-30	$8,118,361	474,758	-76.2%	Shares	Sole	2025-08-14
2025-03-31	$127,511,785	1,997,991	+2.1%	Shares	Sole	2025-05-14
2024-12-31	$237,900,926	1,956,583	+0.5%	Shares	Sole	2025-02-14
2024-09-30	$243,065,913	1,946,240	-0.6%	Shares	Sole	2024-11-14
2024-06-30	$309,464,330	1,958,635	+1.4%	Shares	Sole	2024-08-14
2024-03-31	$250,058,074	1,931,547	+0.6%	Shares	Sole	2024-05-15
2023-12-31	$185,120,721	1,919,742	+1.3%	Shares	Sole	2024-02-14
2023-09-30	$229,750,690	1,895,320	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.